Bradley Scott

CIK 00014105202 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001410520

Recent Transactions

50 trades

Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+48,960→ 57,558,070 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+48,960→ 57,558,070 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+48,960→ 57,558,070 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+2,040→ 3,072,560 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+2,040→ 3,072,560 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+2,040→ 3,072,560 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+2,040→ 3,072,560 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+48,960→ 57,558,070 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+2,040→ 3,072,560 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+2,040→ 3,072,560 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+48,960→ 57,558,070 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-06-10$3.23/sh+48,960→ 57,558,070 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+34,200→ 2,657,680 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+535,800→ 50,706,280 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-05$5.00/sh+52,100→ 2,776,446 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+34,200→ 2,657,680 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-05$5.00/sh+52,100→ 2,776,446 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+535,800→ 50,706,280 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-05$5.00/sh+52,100→ 2,776,446 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+535,800→ 50,706,280 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+535,800→ 50,706,280 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-05$5.00/sh+52,100→ 2,776,446 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+34,200→ 2,657,680 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+34,200→ 2,657,680 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+34,200→ 2,657,680 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-05$3.94/sh+535,800→ 50,706,280 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+104,060→ 49,888,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+18,000→ 2,616,840 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+18,000→ 2,616,840 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+282,000→ 50,170,480 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-04$5.00/sh+13,600→ 2,724,346 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+282,000→ 50,170,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+104,060→ 49,888,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+104,060→ 49,888,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+282,000→ 50,170,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+104,060→ 49,888,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+6,640→ 2,623,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+104,060→ 49,888,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+282,000→ 50,170,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+6,640→ 2,623,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+6,640→ 2,623,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+18,000→ 2,616,840 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-04$5.00/sh+13,600→ 2,724,346 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+6,640→ 2,623,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+18,000→ 2,616,840 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-04$5.00/sh+13,600→ 2,724,346 total
Purchase
PENWEST PHARMACEUTICALS CO
Ordinary Shares
2008-03-04$5.00/sh+13,600→ 2,724,346 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.99/sh+6,640→ 2,623,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+282,000→ 50,170,480 total
Purchase
XTL BIOPHARMACEUTICALS LTD$XTLB
Ordinary Shares
2008-03-04$3.98/sh+18,000→ 2,616,840 total

Companies

Recent Filings

Address

PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR

NEW YORK, NY, 10022

View on SEC.gov